RAET1E and nasopharyngeal carcinoma: Therefore, future combined treatments using conventional cancer therapies and novel immunotherapies, towards enhancing the expression of ULBP4, may provide new therapeutic avenues in the prevention of tumor progression and distant metastasis in patients with NPC.